Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
ASND
ASND
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest ASND ETF News Today | Earnings, Events & Price Alerts
ASND News
Ascendis Pharma Receives FDA Approval for New Drug
2d ago
Benzinga
Ascendis Pharma A/S (ASND.US) Officer Plans to Sell $4.44 Million in Common Stock via Form 144
1d ago
moomoo
Ascendis Pharma Receives FDA Accelerated Approval for YUVIWEL
4d ago
NASDAQ.COM
FDA Approves Ascendis Pharma's Yuviwel for Dwarfism Treatment
4d ago
seekingalpha
FDA Approves First Treatment for Achondroplasia
4d ago
Newsfilter
Ascendis Pharma Receives FDA Approval for YUVIWEL, a Breakthrough Treatment for Achondroplasia
4d ago
Yahoo Finance
Perceptive Advisors Acquires 431,432 Shares of Praxis Precision Medicines
Feb 22 2026
Yahoo Finance
Perceptive Advisors Increases Stake in Celcuity
Feb 22 2026
Yahoo Finance
BridgeBio Pharma Stock Soars on Positive Clinical Trial Results
Feb 12 2026
Benzinga
Ascendis Pharma Reports Strong 2025 Financial Results and Growth Outlook
Feb 12 2026
Yahoo Finance
Ascendis Pharma Reports Strong FY Earnings, Surpassing Expectations
Feb 11 2026
seekingalpha
Ascendis Pharma Reports Strong 2025 Financial Results and Growth Outlook
Feb 11 2026
Yahoo Finance
Ascendis Pharma Q4 Earnings Announcement Scheduled
Feb 10 2026
seekingalpha
FDA Approves Zycubo for Pediatric Menkes Disease Treatment
Jan 28 2026
NASDAQ.COM
Ascendis Pharma (ASND) Stock Rises 7.5% Amid Takeover Speculation
Jan 22 2026
seekingalpha
Ascendis Pharma Updates 2026 Strategic Roadmap, Projects €683 Million Revenue
Jan 09 2026
Globenewswire
Show More News
